June 21,2023

Wyden Statement on PhRMA Lawsuit to Ban Medicare Prescription Drug Negotiation

Washington, D.C. — Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a lawsuit against provisions in the Inflation Reduction Act written to lower the cost of prescription drugs for seniors and taxpayers:

“It’s no surprise that Big Pharma wants to stop Medicare from negotiating lower drug prices on behalf of American seniors,” Wyden said. “I expect the Biden Administration to vigorously defend Medicare’s bargaining power so seniors will see the lower drug prices they expect. This legal action underscores how critical it is to have a president in the White House who will fight for lower health costs for Americans. I have deep concerns that a Republican administration would roll out the red carpet for Big Pharma and once again ban Medicare from negotiating lower drug prices.”